Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
Vertex Pharma raises annual revenue forecast on strong demand for its cystic fibrosis treatments
04:09pm, Thursday, 01'st Aug 2024
Vertex Pharmaceuticals raised its annual revenue forecast on Thursday, betting on robust demand for its cystic fibrosis (CF) treatments.
Vertex Reports Second Quarter 2024 Financial Results
04:01pm, Thursday, 01'st Aug 2024
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the second quarter ended June 30, 2024, and raised its full year product r
Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever
10:15am, Thursday, 01'st Aug 2024
Investing cash in great businesses can set your portfolio up for long-term success. Vertex is paving a profitable path from a portfolio of existing and likely blockbusters.
The Top 3 Biotech Stocks to Buy Now Summer 2024
04:30pm, Wednesday, 31'st Jul 2024
In the bustling world of biotechnology, innovation remains the cornerstone of growth. Some biotech stocks, known for their groundbreaking research and rapid adaptation to health challenges, are partic
Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss?
02:35pm, Tuesday, 30'th Jul 2024
Let's focus on biotech stocks like GSK, VRTX, BIIB, MRNA and REGN, which are scheduled to report this week.
Prime Therapeutics Fails to Silence AHF in PBM Price-Fixing Arbitration
01:32pm, Tuesday, 30'th Jul 2024
LOS ANGELES--(BUSINESS WIRE)--Prime Therapeutics Fails to Silence AHF in PBM Price-Fixing Arbitration.
BMY vs. VRTX: Which Stock Should Value Investors Buy Now?
12:41pm, Tuesday, 30'th Jul 2024
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Bristol Myers Squibb (BMY) and Vertex Pharmaceuticals (VRTX). But which of these two companies is th
Vertex (VRTX) Stock Before Q2 Earnings: To Buy or Not to Buy?
11:45am, Monday, 29'th Jul 2024
Vertex's (VRTX) second-quarter revenues are expected to have been driven by the robust sales of its lead CF product, Trikafta/Kaftrio.
Curious about Vertex (VRTX) Q2 Performance? Explore Wall Street Estimates for Key Metrics
10:21am, Monday, 29'th Jul 2024
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Vertex (VRTX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
2 No-Brainer Growth Stocks to Buy With $1,000 Right Now
04:41am, Sunday, 28'th Jul 2024
These businesses are on very different growth trajectories in opposite industries, but each can have something to offer the long-term investor. Vertex Pharmaceuticals is building out a pipeline of pot
Is Vertex Pharmaceuticals' Monopoly in Danger?
08:15am, Thursday, 25'th Jul 2024
Vertex's dominance in the cystic fibrosis drug market could be challenged. Even in the worst-case scenario, its challenger's products won't be launched soon.
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
04:10am, Thursday, 25'th Jul 2024
Vertex Pharmaceuticals has built a billion-dollar cystic fibrosis business over time. But the company today may be preparing for a new era of growth, thanks to the strength of its pipeline.
Vertex Pharmaceuticals (VRTX) Rises As Market Takes a Dip: Key Facts
06:56pm, Wednesday, 24'th Jul 2024
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $490.80, denoting a +0.1% change from the preceding trading day.
Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock
10:03am, Wednesday, 24'th Jul 2024
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
7 Biotech Stocks to Keep on Your Clinical Radar
02:57pm, Tuesday, 23'rd Jul 2024
Initially, I had every intention to write a cookie-cutter assessment of intriguing biotech stocks; that is, I wanted to say that enterprises within this specialized healthcare field will always be rel
